Absci (ABSI) Retained Earnings (2021 - 2026)
Absci's (ABSI) quarterly Retained Earnings came in at $304000.0 in Q1 2026, up 100.06% year-on-year from $151956.9 in Q1 2025, and down 48.56% quarter-over-quarter from $591000.0 in Q4 2025.
Absci (ABSI) Retained Earnings (2021 - 2026) Analysis & Trends
Absci has disclosed Retained Earnings across 6 years of filings, most recently posting $304000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at $304000.0, up 100.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $304000.0 (up 100.06% YoY), and the FY2025 annual result was $591000.0, up 14875.0% from the prior year.
- Retained Earnings came in at $304000.0 for Q1 2026 at Absci, down from $591000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $591000.0 in Q4 2025 to a low of -$535.9 million in Q1 2025.
- The 5-year median for Retained Earnings is -$61000.0 (2022), against an average of -$124.6 million.
- Across the five-year window, Retained Earnings tumbled 814506.78% in 2024 and soared 14875.0% in 2025, its largest moves.
- Absci's Retained Earnings stood at -$120000.0 in 2022, then surged by 69.17% to -$37000.0 in 2023, then soared by 89.19% to -$4000.0 in 2024, then jumped by 14875.0% to $591000.0 in 2025, then slumped by 48.56% to $304000.0 in 2026.
- The last three Retained Earnings figures came in at $304000.0 (Q1 2026), $591000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 304,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 591,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | -535.95 Mn |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | -480.62 Mn |
| Jun 30, 2024 | -453.22 Mn |
| Mar 31, 2024 | -428.47 Mn |
| Dec 31, 2023 | -37,000.00 |
| Sep 30, 2023 | -59,000.00 |
| Jun 30, 2023 | -146,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Dec 31, 2022 | -120,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | -61,000.00 |
| Mar 31, 2022 | -220.52 Mn |
| Dec 31, 2021 | -13,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | -11,000.00 |